1. Risk factors for Alzheimer’s disease;A Armstrong;Folia Neuropathol.,2019
2. Multi-target directed ligands (MTDLs) binding the σ1 receptor as promising therapeutics: state of the Art and perspectives;Abatematteo;Int. J. Mol. Sci.,2021
3. Resveratrol-selenium nanoparticles alleviate neuroinflammation and neurotoxicity in a rat model of Alzheimer’s disease by regulating Sirt1/miRNA-134/GSK3β expression;Abozaid;Biol. Trace Elem. Res.,2022
4. Peptide aptamer targeting Aβ–PrP–Fyn axis reduces Alzheimer’s disease pathologies in 5XFAD transgenic mouse model;Ali;Cell. Mol. Life Sci.,2023
5. Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus;Ali;Sci. Rep.,2015